INMUNOL. Y BACTERIOL.APLICADA AL DIAGNOSTICO DE LOS VIRUS DE TRANSMISION HEMATICA, CON ESPECIAL DEDICACION A HEPATITIS Y SIDA
INMUNOL. Y BACTERIOL.APLICADA
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (11)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Effects of COVID-19-Associated Pulmonary Aspergillosis (CAPA) on the prognosis of severe COVID-19: Clinical characteristics and risk factors in a second-level hospital from Southern Spain
Enfermedades Infecciosas y Microbiologia Clinica
-
Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain
Infection
-
Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain
Health Science Reports, Vol. 7, Núm. 3
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia
International journal of molecular sciences, Vol. 24, Núm. 3
-
Gut Microbiota Composition Can Predict Colonization by Multidrug-Resistant Bacteria in SARS-CoV-2 Patients in Intensive Care Unit: A Pilot Study
Antibiotics, Vol. 12, Núm. 3
-
Molecular characterization of patients with chronic hepatitis C virus infection in Jordan: implications on response to direct-acting antiviral therapy
International Journal of Infectious Diseases, Vol. 135, pp. 63-66
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
In vitro neutralizing activity of BNT162b2 mRNA-induced antibodies against full B.1.351 SARS-CoV-2 variant
Transboundary and Emerging Diseases, Vol. 69, Núm. 5, pp. 2649-2655
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836